http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002503225-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate | 1998-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002503225-A |
| titleOfInvention | Pharmaceutical compositions for immunosuppressive, anticancer and antiviral treatments |
| abstract | (57) Abstract: A compound and its use for the preparation of a pharmaceutical composition as an immunosuppressant, an anticancer and an antiviral, comprising a compound of the formula (IV) Is H, PO 3 = , substituted or unsubstituted, linear or branched, alkyl of 1 to 12 carbon atoms with 0 to 6 double bonds, (CH 2 ) n morpholine (n = 1-4), morpholinomethylphenyl, orthoaminophenyl, orthohydroxyphenyl, (CH 2 ) n COOR 2 (n = 1-4) (where R 2 is H, an alkali metal salt, an alkaline earth metal salt) , NH 4 + , N + (R 3 ) 4 , wherein R 3 is independently selected from the group consisting of H and alkyl of 1 to 4 carbon atoms), or COR 1 , wherein R 1 is , H, (CH 2) n CH 3 (n = 0-6), (CH 2) n COO 2 (n = 1-4, and R 2 are as defined above), (CH 2) n N + (R 3) 4 (n = 1-4), and, (CH 2) n SO 3 - (n = 1-4) is selected from the group consisting of 1-4). |
| priorityDate | 1997-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 338.